Debevoise Advises TPG and OneOncology on Sale of TPG Equity Interest in OneOncology to Cencora at $7.4 Billion Enterprise Value

Debevoise advised TPG and OneOncology in connection with the sale of TPG’s equity interest in OneOncology to Cencora. The transaction involves Cencora’s acquisition of TPG’s equity interest in OneOncology at an enterprise value of $7.4 billion. Debevoise represented TPG and OneOncology with a team composed by: M&A partners Spencer Gilbert and Erik Andrén; associates Robert Geren, Luke Glavin, Richard Hughes and Matthew Ryan; law clerk Jason Bach; tax partners Michael Bolotin and Stephen Jordan and counsel Samuel Krawiecz; employee benefits and executive compensation partner Jonathan Lewis, counsel Kathleen Emberger and law clerk Annie Zhou; and antitrust partner Tim Cornell and associate Adam Saunders.

Debevoise Advises TPG and OneOncology on Sale of TPG Equity Interest in OneOncology to Cencora at $7.4 Billion Enterprise Value

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads